Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2022	May 01, 2021
Cash flows from operating activities:
Net income	$ 13,388	$ 8,697
Adjustments to reconcile net income to net cash provided by (used for) operating activities:
Amortization and write-off of deferred debt issuance costs	19	215
Impairment (gain) of assets	(351)	(652)
Depreciation and amortization	3,987	4,500
Stock compensation expense	366	327
Board of directors stock compensation	125	109
Changes in operating assets and liabilities:
Accounts receivable	938	1,745
Inventories	(15,104)	(3,362)
Prepaid expenses and other current assets	(1,462)	(2,692)
Other assets	(20)	4
Accounts payable	4,248	4,548
Operating leases, net	(1,874)	(6,318)
Accrued expenses and other liabilities	(5,803)	644
Net cash provided by (used for) operating activities	(1,543)	7,765
Cash flows from investing activities:
Additions to property and equipment, net	(1,184)	(803)
Net cash used for investing activities	(1,184)	(803)
Cash flows from financing activities:
Repurchase of common stock	(4,847)
Proceeds from issuance of common stock from private direct offering, net of offering costs		4,375
Repayment of FILO loan		(15,000)
Proceeds from new FILO loan		17,500
Net repayments under credit facility		(26,173)
Debt issuance costs		(818)
Tax withholdings paid related to net share settlements	(415)
Proceeds from the exercise of stock options	23
Net cash used for financing activities	(5,239)	(20,116)
Net decrease in cash and cash equivalents	(7,966)	(13,154)
Cash and cash equivalents:
Beginning of period	15,506	18,997
End of period	$ 7,540	$ 5,843